The human synovial fluid proteome: A key factor in the pathology of joint disease

David S. Gibson, Madeleine E. Rooney

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

This review aims to summarise our knowledge to date on the protein complement of the synovialfluid (SF). The tissues, structure and pathophysiology of the synovial joint are briefly described.The salient features of the SF proteome, how it is composed and the influence of arthritic diseaseare highlighted and discussed. The concentrations of proteins that have been detected andquantified in SF are drawn together from the literature on osteoarthritis, rheumatoid arthritisand juvenile idiopathic arthritis. The measurements are plotted to give a perspective on the dynamicrange of protein levels within the SF. Approaches to proteomic analysis of SF to date arediscussed along with their findings. From the recent literature reviewed within, it is becomingincreasingly clear that analysis of the SF proteome as a whole, could deliver the most valuabledifferential diagnostic fingerprints of a number of arthritic disorders. Further development ofproteomic platforms could characterise prognostic profiles to improve the clinician’s ability toresolve unremitting disease by existing and novel therapeutics.
LanguageEnglish
Pages889-899
JournalProteomics - Clinical Applications
Volume1
Issue number8
DOIs
Publication statusPublished - 13 Jul 2007

Fingerprint

Joint Diseases
Synovial Fluid
Proteome
Arthritis
Pathology
Juvenile Arthritis
Dermatoglyphics
Osteoarthritis
Proteomics
Complement System Proteins
Proteins
Joints
Therapeutics

Keywords

  • Synovial fluid
  • proteome
  • arthritis
  • mass spectrometry
  • inflammation

Cite this

@article{f819e7b7f2f047d2914e4d16bb0a4ffb,
title = "The human synovial fluid proteome: A key factor in the pathology of joint disease",
abstract = "This review aims to summarise our knowledge to date on the protein complement of the synovialfluid (SF). The tissues, structure and pathophysiology of the synovial joint are briefly described.The salient features of the SF proteome, how it is composed and the influence of arthritic diseaseare highlighted and discussed. The concentrations of proteins that have been detected andquantified in SF are drawn together from the literature on osteoarthritis, rheumatoid arthritisand juvenile idiopathic arthritis. The measurements are plotted to give a perspective on the dynamicrange of protein levels within the SF. Approaches to proteomic analysis of SF to date arediscussed along with their findings. From the recent literature reviewed within, it is becomingincreasingly clear that analysis of the SF proteome as a whole, could deliver the most valuabledifferential diagnostic fingerprints of a number of arthritic disorders. Further development ofproteomic platforms could characterise prognostic profiles to improve the clinician’s ability toresolve unremitting disease by existing and novel therapeutics.",
keywords = "Synovial fluid, proteome, arthritis, mass spectrometry, inflammation",
author = "Gibson, {David S.} and Rooney, {Madeleine E.}",
year = "2007",
month = "7",
day = "13",
doi = "10.1002/prca.200700044",
language = "English",
volume = "1",
pages = "889--899",
journal = "Proteomics - Clinical Applications",
issn = "1862-8346",
number = "8",

}

The human synovial fluid proteome: A key factor in the pathology of joint disease. / Gibson, David S.; Rooney, Madeleine E.

In: Proteomics - Clinical Applications, Vol. 1, No. 8, 13.07.2007, p. 889-899.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The human synovial fluid proteome: A key factor in the pathology of joint disease

AU - Gibson, David S.

AU - Rooney, Madeleine E.

PY - 2007/7/13

Y1 - 2007/7/13

N2 - This review aims to summarise our knowledge to date on the protein complement of the synovialfluid (SF). The tissues, structure and pathophysiology of the synovial joint are briefly described.The salient features of the SF proteome, how it is composed and the influence of arthritic diseaseare highlighted and discussed. The concentrations of proteins that have been detected andquantified in SF are drawn together from the literature on osteoarthritis, rheumatoid arthritisand juvenile idiopathic arthritis. The measurements are plotted to give a perspective on the dynamicrange of protein levels within the SF. Approaches to proteomic analysis of SF to date arediscussed along with their findings. From the recent literature reviewed within, it is becomingincreasingly clear that analysis of the SF proteome as a whole, could deliver the most valuabledifferential diagnostic fingerprints of a number of arthritic disorders. Further development ofproteomic platforms could characterise prognostic profiles to improve the clinician’s ability toresolve unremitting disease by existing and novel therapeutics.

AB - This review aims to summarise our knowledge to date on the protein complement of the synovialfluid (SF). The tissues, structure and pathophysiology of the synovial joint are briefly described.The salient features of the SF proteome, how it is composed and the influence of arthritic diseaseare highlighted and discussed. The concentrations of proteins that have been detected andquantified in SF are drawn together from the literature on osteoarthritis, rheumatoid arthritisand juvenile idiopathic arthritis. The measurements are plotted to give a perspective on the dynamicrange of protein levels within the SF. Approaches to proteomic analysis of SF to date arediscussed along with their findings. From the recent literature reviewed within, it is becomingincreasingly clear that analysis of the SF proteome as a whole, could deliver the most valuabledifferential diagnostic fingerprints of a number of arthritic disorders. Further development ofproteomic platforms could characterise prognostic profiles to improve the clinician’s ability toresolve unremitting disease by existing and novel therapeutics.

KW - Synovial fluid

KW - proteome

KW - arthritis

KW - mass spectrometry

KW - inflammation

U2 - 10.1002/prca.200700044

DO - 10.1002/prca.200700044

M3 - Article

VL - 1

SP - 889

EP - 899

JO - Proteomics - Clinical Applications

T2 - Proteomics - Clinical Applications

JF - Proteomics - Clinical Applications

SN - 1862-8346

IS - 8

ER -